Technology: Cell_Therapies, Neurological Disorders, Service
Industry: Biotechnology, Private
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2017-01-01
Employees Number: 101-250
Funding Status: Late Stage Venture
Number Of Exits: 1
Investors Number: 16
Total Funding: 845000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-03-15
Last Funding Type: Series C

Visit Website
info@elevate.bio
https://twitter.com/elevatebio
Register and Claim Ownership